WebJul 27, 2024 · GENFIT Officially Terminates RESOLVE-IT Trial of Elafibranor in NASH July 22, 2024 Impact: High GENFIT has officially terminated its pivotal RESOLVE-IT trial of elafibranor for the treatment of NASH with fibrosis after it … WebJul 22, 2024 · Complete corporate strategy update to be announced end of September 2024. Lille (France), Cambridge (Massachusetts, United States), July 22, 2024– GENFIT …
GENFIT Reports Full-Year 2024 Financial Results and Provides …
WebDec 31, 2024 · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995 in relation to its timelines for topline data readout for our ELATIVE® Phase 3 trial, potential for positive ELATIVE® Phase 3 results, eligibility to meet milestones ... WebJan 24, 2024 · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, in relation to GENFIT’s research and development programs and planned release of financial information. chrome wont stop using yahoo
GENFIT: Announces Results from Interim Analysis of RESOLVE-IT
Web15 hours ago · GENFIT tiendra une conférence téléphonique en anglais et en français le 14 avril 2024 à 08h00 ET / 13h00 GMT / 14h00 CET . Les deux conférences téléphoniques … WebLille (France), Cambridge (Massachusetts, United States), March 10, 2016– GENFIT (Euronext: GNFT – ISIN: FR0004163111), a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announced that it has … Web15 hours ago · GENFIT FORWARD LOOKING STATEMENTS This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation ... chrome won\u0027t download files